InfuSystems Holdings, Inc. (INFU) Tops Q2 Earnings Estimates
InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.03 per share a year ago.
Is the Options Market Predicting a Spike in InfuSystems Holdings Stock?
Investors need to pay close attention to InfuSystems Holdings stock based on the movements in the options market lately.
InfuSystem: Investments Are Starting To Pay Off
InfuSystem offers integrated clinic-to-home healthcare solutions, leveraging strong payer networks, strategic partnerships, and economies of scale to drive recurring revenue and margin expansion. Recent growth is fueled by diversification into wound care and biomedical services, with Q1 showing double-digit Patient Services revenue growth and record adjusted EBITDA margins. The company's valuation is attractive, trading at just 5.4x FY25 EV/EBITDA, with limited tariff or economic cycle risk and capital spending expected to moderate.
InfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU ) Q1 2025 Earnings Call May 8, 2025 9:00 AM ET Company Participants Joe Dorame - Managing Partner Richard Dilorio - CEO Barry Steele - EVP and CFO Carrie Lachance - President and COO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Unidentified Analyst - Craig-Hallum Capital Group Jim Sidoti - Sidoti & Company Anderson Schock - B. Riley Securities Operator Good day and welcome to the InfuSystem Holdings, Inc. Reports First Quarter 2025 Financial Results Conference Call.
InfuSystems Holdings, Inc. (INFU) Reports Q1 Loss, Tops Revenue Estimates
InfuSystems Holdings, Inc. (INFU) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.05 per share a year ago.
InfuSystem Holdings, Inc. (INFU) Q4 2024 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU ) Q4 2024 Results Conference Call March 4, 2025 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Kyle Bauser - B. Riley Securities Jim Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings Inc. Reports Fourth Quarter and Full Year 2024 Financial Results Conference Call.
InfuSystems Holdings, Inc. (INFU) Misses Q4 Earnings and Revenue Estimates
InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to break-even earnings per share a year ago.
InfuSystem Set For Strong Year
InfuSystem Holdings achieved 11% YoY revenue growth and expanded EBITDA margins by 2.8 percentage points in 3Q24. INFU's business plan focuses on high ROI revenue and less capital-intensive growth through partnerships, leading to higher margins and cash flows. Near-term growth drivers include agreements with Smith+Nephew, SMTI, and Dignitana, expected to boost FY25 revenue and margin expansion.
InfuSystem Holdings, Inc. (INFU) Q3 2024 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU ) Q3 2024 Results Conference Call November 7, 2024 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Jim Sidoti - Sidoti & Company Brooks O'Neil - Lake Street Capital Markets Kyle Bauser - B. Riley Securities Matt Hewitt - Craig-Hallum Capital Group Aaron Warwick - Breakout Investors Operator Good day, and welcome to the InfuSystem Third Quarter of 2024 Financial Results Conference Call.
The Future of Medical Devices: Two Strong Buys You Can't Miss
The medical device market, a powerhouse sector, is projected to exceed $600 billion by 2025. This growth is fueled by a combination of factors, including an aging population, rising healthcare costs, and rapid technological advancements powered by advanced artificial intelligence (AI) and biotechnology.
InfuSystem Set For Strong Second Half
InfuSystem's stock could soar in late 2024 and throughout 2025 after consolidating in the sub-$7.00/share range. INFU's underlying business is stronger than ever, with new partnerships and revenue streams set to surprise the market. The company's pivot toward partnering with established players is expected to drive revenue growth and expanding margins.
InfuSystem Holdings, Inc. (INFU) Q2 2024 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU ) Q2 2024 Earnings Call Transcript August 8, 2024 9:00 AM ET Company Participants Joe Dorame - Investor Relations Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Matt Hewitt - Craig-Hallum Capital Group Jim Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings, Inc. Second Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.
